KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Share-based Compensation (2016 - 2026)

Eli Lilly filings provide 18 years of Share-based Compensation readings, the most recent being $161.0 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 4.55% to $161.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $633.0 million, a 1.19% decrease, with the full-year FY2025 number at $626.0 million, down 3.1% from a year prior.
  • Share-based Compensation hit $161.0 million in Q1 2026 for Eli Lilly, up from $136.1 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $215.6 million in Q3 2023 to a low of $85.1 million in Q3 2022.
  • Median Share-based Compensation over the past 5 years was $142.3 million (2024), compared with a mean of $143.1 million.
  • Biggest five-year swings in Share-based Compensation: surged 153.35% in 2023 and later plummeted 38.22% in 2024.
  • Eli Lilly's Share-based Compensation stood at $92.9 million in 2022, then increased by 29.92% to $120.7 million in 2023, then grew by 17.9% to $142.3 million in 2024, then decreased by 4.36% to $136.1 million in 2025, then increased by 18.3% to $161.0 million in 2026.
  • The last three reported values for Share-based Compensation were $161.0 million (Q1 2026), $136.1 million (Q4 2025), and $151.1 million (Q3 2025) per Business Quant data.